Zymeworks (ZYME) Reiterated at Buy by Stifel After AACR Presentation

April 22, 2026 7:59 AM

Stifel analyst Stephen Willey reiterated a Buy rating and $47.00 price target on Zymeworks (NASDAQ: ZYME).The analyst commented, "The AACR ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found